nadp has been researched along with 1-methyl-4-phenylpyridinium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mizuno, Y; Saitoh, T; Sone, N | 1 |
Arora, PK; Blumer, JL; Frank, DM; Sayre, LM | 1 |
Kalgutkar, AS; Nguyen, HT | 1 |
3 other study(ies) available for nadp and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain; Citric Acid Cycle; In Vitro Techniques; Ketoglutarate Dehydrogenase Complex; Ketone Oxidoreductases; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD; NADP; Oxygen Consumption; Pyridinium Compounds | 1987 |
Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Cytochrome P-450 Enzyme System; Microsomes, Liver; NADP; Oxidation-Reduction; Paraquat; Pyridines; Pyridinium Compounds; Structure-Activity Relationship | 1987 |
Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antidiarrheals; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Dealkylation; Haloperidol; Humans; Hydroxylation; Ketoconazole; Loperamide; Male; Microsomes, Liver; NADP; Neurons; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Time Factors | 2004 |